Roche to pay $21M to Enzo Biochem over alleged patent infringement – Seeking Alpha


Roche (OTCQX:RHHBY -0.4%) has agreed to pay Enzo Biochem (ENZ -0.7%) $21M to settle patent infringement litigation related to the use of labeled nucleotides in genetic testing. ENZ sued Roche, Gen-Probe and Life Technologies in 2012 over U.S. Patent No. 6,992,180.

EZN says the settlement does not affect its civil action against Roche which is currently under appeal.



Source link




Leave a Reply

Your email address will not be published. Required fields are marked *